Comparison of efficacy and safety of escitalopram and vilazodone in major depressive disorder
Background: Major depressive disorder (MDD) is a worldwide prevalent psychiatric ailment associated with significant morbidity and mortality. Escitalopram is an effective selective serotonin reuptake inhibitor (SSRI), and vilazodone is a newer SSRI and partial serotonin receptor agonist approved for...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Eldaghayes Publisher
2018-08-01
|
| Seri Bilgileri: | National Journal of Physiology, Pharmacy and Pharmacology |
| Konular: | |
| Online Erişim: | http://www.ejmanager.com/fulltextpdf.php?mno=296243 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|